Erythritol-based dry powder of glucagon for pulmonary administration

International Journal of Pharmaceutics

Volumn 290, Issue 1-2, 2005, Pages 63-71

  Endo, Kosuke ^a   Amikawa, Satoko ^a   Matsumoto, Asami ^a   Sahashi, Norio ^b   Onoue, Satomi ^a,b,c  

^a Ito Life Sciences Inc   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c PFIZER INC   (United States)

Author keywords

Carrier; Dry powder inhalant; Erythritol; Excipient; Glucagon; Pulmonary absorption

Indexed keywords

ERYTHRITOL; GLUCAGON; GLUCOSE; LACTOSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRY POWDER; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; LASER DIFFRACTION; LUNG DIFFUSION CAPACITY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD GLUCOSE; ERYTHRITOL; GLUCAGON; LUNG; MALE; PARTICLE SIZE; POWDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 12344276697     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.11.018     Document Type: Article

References (30)

1. G.H. Beaven, W.B. Gratzer, and H.G. Davies Formation and structure of gels and fibrils from glucagon Eur. J. Biochem. 11 1969 37 42
2. G. Boden, R.W. Master, I. Rezvani, J.P. Palmer, T.E. Lobe, and O.E. Owen Glucagon deficiency and hyperaminoacidemia after total pancreatectomy J. Clin. Invest. 65 1980 706 716
3. N. Geary Effects of glucagon, insulin, amylin and CGRP on feeding Neuropeptides 33 1999 400 405
4. R.W. Gelling, X.Q. Du, D.S. Dichmann, J. Romer, H. Huang, L. Cui, S. Obici, B. Tang, J.J. Holst, C. Fledelius, P.B. Johansen, L. Rossetti, L.A. Jelicks, P. Serup, E. Nishimura, and M.J. Charron Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice Proc. Natl. Acad. Sci. U.S.A. 100 2003 1438 1443
5. M. Gumbleton Caveolae as potential macromolecule trafficking compartments within alveolar epithelium Adv. Drug Deliv. Rev. 49 2001 281 300
6. J.H. Hagen Effect of glucagon on the metabolism of adipose tissue J. Biol. Chem. 236 1961 1023 1027
7. L.H. Hansen, N. Abrahamsen, and E. Nishimura Glucagon receptor mRNA distribution in rat tissues Peptides 16 1995 1163 1166
8. M. Hirota, S. Ikei, M. Mishima, K. Mori, K. Sakamoto, T. Yamane, K. Idegami, S. Katafuchi, H. Kiyohara, Y. Nakashima, M. Nakano, and M. Akagi Glucagon in the metabolic and nutritional management after total pancreatectomy - a case report Jpn. J. Surg. 19 1989 586 592
9. K. Hupe-Sodmann, R. Goke, B. Goke, H.H. Thole, B. Zimmermann, K. Voigt, and G.P. McGregor Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells Peptides 18 1997 625 632
10. M. Ishikawa, M. Miyashita, Y. Kawashima, T. Nakamura, N. Saitou, and J. Modderman Effects of oral administration of erythritol on patients with diabetes Regul. Toxicol. Pharmacol. 24 1996 S303 S308
11. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate Int. J. Pharm. 172 1998 179 188
12. Y. Liu, and D. Schubert Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity J. Neurochem. 71 1998 2322 2329
13. A. Miyata, A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, L. Jiang, M.D. Culler, and D.H. Coy Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem. Biophys. Res. Commun. 164 1989 567 574
14. E. Mochiki, H. Suzuki, S. Takenoshita, Y. Nagamachi, H. Kuwano, A. Mizumoto, and Z. Itoh Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon J. Gastroenterol. 33 1998 835 841
15. W.A. Muller, M. Berger, P. Suter, H.J. Cuppers, J. Reiter, T. Wyss, P. Berchtold, F.H. Schmidt, J.P. Assal, and A.E. Renold Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients J. Clin. Invest. 63 1979 820 827
16. W.A. Muller, H.J. Cuppers, H. Zimmermann-Telschow, H. Micheli, T. Wyss, A.E. Renold, and M. Berger Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts Eur. J. Clin. Invest. 13 1983 141 149
17. K. Noda, K. Nakayama, and T. Oku Serum glucose and insulin levels and erythritol balance after oral administration of erythritol in healthy subjects Eur. J. Clin. Nutr. 48 1994 286 292
18. S. Onoue, K. Ohshima, K. Endo, T. Yajima, and K. Kashimoto PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106-126 FEBS Lett. 522 2002 65 70
19. S. Onoue, Y. Waki, K. Hamanaka, T. Yajima, and K. Kashimoto Vasoactive intestinal peptide regulates catecholamine secretion in rat PC12 cells through the pituitary adenylate cyclase activating polypeptide receptor Biomed. Res. 22 2001 77 82
20. J.S. Patton Mechanisms of macromolecule absorption by the lungs Adv. Drug Deliv. Rev. 19 1996 3 36
21. D.G. Pipeleers, F.C. Schuit, P.A. in't Veld, E. Maes, E.L. Hooghe-Peters, M. Van de Winkel, and W. Gepts Interplay of nutrients and hormones in the regulation of insulin release Endocrinology 117 1985 824 833
22. A.E. Pontiroli, A. Calderara, E. Pajetta, M. Alberetto, and G. Pozza Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients Diabetes Care 12 1989 604 608
23. D. Prime, P.J. Atkins, A. Slater, and B. Sumby Review of dry powder inhalers Adv. Drug Deliv. Rev. 26 1997 51 58
24. A.M. Rosenfalck, I. Bendtson, S. Jorgensen, and C. Binder Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients Diabetes Res. Clin. Pract. 17 1992 43 50
25. S.K. Tee, C. Marriott, X.M. Zeng, and G.P. Martin The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate Int. J. Pharm. 208 2000 111 123
26. D. Teshima, A. Yamauchi, K. Makino, Y. Kataoka, Y. Arita, H. Nawata, and R. Oishi Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers Int. J. Pharm. 233 2002 61 66
27. D. Vaudry, B.J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions Pharmacol. Rev. 52 2000 269 324
28. B.M. Wallace, and J.S. Lasker Stand and deliver: getting peptide drugs into the body Science 260 1993 912 913
29. L.X. Yu, E. Lipka, J.R. Crison, and G.L. Amidon Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption Adv. Drug Deliv. Rev. 19 1996 359 376
30. X.M. Zeng, A.P. Martin, C. Marriott, and J. Pritchard The influence of carrier morphology on drug delivery by dry powder inhalers Int. J. Pharm. 200 2000 93 106